TRULICITY

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States

Active ingredients

The drug TRULICITY contains one active pharmaceutical ingredient (API):

1 Dulaglutide UNII WTT295HSY5 - DULAGLUTIDE

Dulaglutide is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist. In contrast to native GLP-1, dulaglutide is resistant to degradation by DPP-4, and has a large size that slows absorption and reduces renal clearance. Dulaglutide improves glycaemic control through the sustained effects of lowering fasting, pre-meal and postprandial glucose concentrations in patients with type 2 diabetes. Read about Dulaglutide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TRULICITY Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BJ05		A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BJ Glucagon-like peptide-1 (GLP-1) analogues
Discover more medicines within A10BJ05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11364D
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 507615120019102, 507615120019202, 507615120019302, 507615120019402, 507615120019502, 507615120019602
Country: CA	Health Products and Food Branch	Identifier(s): 02448599, 02448602
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 33-MBE-1115, 38-MBE-0116
Country: EE	Ravimiamet	Identifier(s): 1670701, 1670712, 1670723, 1670734, 1670745, 1670756, 1670778, 1670789, 1670790, 1670802, 1832644, 1832655, 1832666, 1832677, 1832688, 1832699
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 114956002, 114956007
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 391550, 564626
Country: FR	Base de données publique des médicaments	Identifier(s): 62733600, 63787647
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 284611, 284625, 392327, 392331
Country: HK	Department of Health Drug Office	Identifier(s): 64233, 64234
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7841, 7842
Country: IT	Agenzia del Farmaco	Identifier(s): 043783012, 043783024, 043783036, 043783048, 043783051, 043783063, 043783075, 043783087, 043783099, 043783101, 043783113, 043783125, 043783137, 043783149, 043783152, 043783164
Country: JP	医薬品医療機器総合機構	Identifier(s): 2499416G1029
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1075116, 1075117, 1075118, 1075431, 1075432, 1075433, 1075434, 1075435, 1075436, 1075437, 1091503, 1091504, 1091505, 1091506, 1091507, 1091508
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 124141, 124168, 206539, 206547
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 21737
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100332791, 100332845, 100446649, 100446655, 100446661, 100463067
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W61461001, W61462001, W61462002, W67148001, W67149001
Country: SG	Health Sciences Authority	Identifier(s): 14967P, 14968P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699673954394, 8699673954400, 8699673954431, 8699673954448
Country: US	FDA, National Drug Code	Identifier(s): 0002-1433, 0002-1434, 0002-2236, 0002-3182, 50090-3484